Home LiteratureArticle Details
PMID: 34442437 Published · epublish English Journal Article

Risk Factors for Recanalization after Coil Embolization.

Journal of personalized medicine ·Vol. 11 ·No. 8 ·2021-08-14

Wiśniewski K, Tyfa Z, Tomasik B, Reorowicz P, Bobeff EJ, Posmyk BJ, Hupało M, Stefańczyk L, Jóźwik K, Jaskólski DJ

Abstract

The aim of our study was to identify risk factors for recanalization 6 months after coil embolization using clinical data followed by computational fluid dynamics (CFD) analysis. Firstly, clinical data of 184 patients treated with coil embolization were analyzed retrospectively. Secondly, aneurysm models for high/low recanalization risk were generated based on ROC curves and their cut-off points. Afterward, CFD was utilized to validate the results. In multivariable analysis, aneurysm filling during the first embolization was an independent risk factor whilst packing density was a protective factor of recanalization after 6 months in patients with aSAH. For patients with unruptured aneurysms, packing density was found to be a protective factor whilst the aneurysm neck size was an independent risk factor. Complex flow pattern and multiple vortices were associated with aneurysm shape and were characteristic of the high recanalization risk group. Statistical analysis suggested that there are various factors influencing recanalization risk. Once certain values of morphometric parameters are exceeded, a complex flow with numerous vortices occurs. This phenomenon was revealed due to CFD investigations that validated our statistical research. Thus, the complex flow pattern itself can be treated as a relevant recanalization predictor.

Keywords
coils complex flow patterns computational fluid dynamics embolization flow diverters predictors recanalization
作者与单位
共 10 位作者,点击展开单位 / ORCID
Wiśniewski Karol
Department of Neurosurgery and Neurooncology, Medical University of Lodz, Kopcińskiego 22, 90-153 Lodz, Poland.
Tyfa Zbigniew
Institute of Turbomachinery, Medical Apparatus Division, Lodz University of Technology, Wolczanska 219/223, 90-924 Lodz, Poland.
Tomasik Bartłomiej ORCID
Department of Biostatistics and Translational Medicine, Medical University of Lodz, 15 Mazowiecka St., 92-215 Lodz, Poland. | Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Reorowicz Piotr ORCID
Institute of Turbomachinery, Medical Apparatus Division, Lodz University of Technology, Wolczanska 219/223, 90-924 Lodz, Poland.
Bobeff Ernest J ORCID
Department of Neurosurgery and Neurooncology, Medical University of Lodz, Kopcińskiego 22, 90-153 Lodz, Poland.
Posmyk Bartłomiej J
Department of Neurosurgery and Neurooncology, Medical University of Lodz, Kopcińskiego 22, 90-153 Lodz, Poland.
Hupało Marlena
Department of Neurosurgery and Neurooncology, Medical University of Lodz, Kopcińskiego 22, 90-153 Lodz, Poland.
Stefańczyk Ludomir
Department of Radiology-Diagnostic Imaging, Medical University of Lodz, Kopcińskiego 22, 90-153 Lodz, Poland.
Jóźwik Krzysztof
Institute of Turbomachinery, Medical Apparatus Division, Lodz University of Technology, Wolczanska 219/223, 90-924 Lodz, Poland.
Jaskólski Dariusz J ORCID
Department of Neurosurgery and Neurooncology, Medical University of Lodz, Kopcińskiego 22, 90-153 Lodz, Poland.
Article Info
Journal
Journal of personalized medicine
Abbr.
J Pers Med
ISSN
2075-4426
Published
2021-08-14
电子出版
2021-00-14
Language
English
Country/Region
Switzerland
NLM ID
101602269
基金资助
Narodowe Centrum Badań i Rozwoju · LIDER/12/0056/L-10/18/NCBR/2019
Medical University of Lodz (statutory activities) · 503-11-001-19-00
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]